Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab.

about

Prognostic significance of vascular endothelial growth factor polymorphisms in colorectal cancer patients.Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer.

P2860

Q42320903-C34DE7F4-9521-4072-AC2D-17D3728C9DDC Q47761632-BFBFD37C-4E5E-4DE6-BC2F-8ACFC5186C46

P2860

Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab.

Item

http://www.wikidata.org/entity/Q53261351

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Significant effect of VEGFA po ...... reated with FOLFIRI-cetuximab.

@en

Significant effect of VEGFA po ...... reated with FOLFIRI-cetuximab.

@nl

type

Item

label

Significant effect of VEGFA po ...... reated with FOLFIRI-cetuximab.

@en

Significant effect of VEGFA po ...... reated with FOLFIRI-cetuximab.

@nl

prefLabel

Significant effect of VEGFA po ...... reated with FOLFIRI-cetuximab.

@en

Significant effect of VEGFA po ...... reated with FOLFIRI-cetuximab.

@nl

P1476

Significant effect of VEGFA po ...... reated with FOLFIRI-cetuximab.

@en

P2093

Alain Morel

http://www.w3.org/2001/XMLSchema#string

Audrey Payancé

http://www.w3.org/2001/XMLSchema#string

Erick Gamelin

http://www.w3.org/2001/XMLSchema#string

Hervé Watier

http://www.w3.org/2001/XMLSchema#string

Jérôme Rollin

http://www.w3.org/2001/XMLSchema#string

Michelle Boisdron-Celle

http://www.w3.org/2001/XMLSchema#string

Nicolas Azzopardi

http://www.w3.org/2001/XMLSchema#string

Thierry Lecomte

http://www.w3.org/2001/XMLSchema#string

Valérie Gouilleux-Gruart

http://www.w3.org/2001/XMLSchema#string

Yves Gruel

http://www.w3.org/2001/XMLSchema#string

P2860

Association between Polymorphisms in Vascular Endothelial Growth Factor Gene and Response to Chemotherapies in Colorectal Cancer: A Meta-Analysis

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Molecular determinants of cetuximab efficacy.

The biological properties of cetuximab.

Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer.

Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: beyond KRAS mutations.

The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression.

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan.

Specific haplotypes of the P-selectin gene are associated with myocardial infarction.

P304

2035-2043

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.15.139

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gilles Paintaud

P577

2015-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26615857

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

cetuximab

Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab.

about

P2860

P2860

Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921